3 March 2021
Brii Biosciences Antibody Combination Will Not Progress into a Phase 3 Study Evaluating the Treatment of SARS-CoV-2 in Hospitalized Patients
December 17, 2020
Brii Biosciences Provides Corporate Update on Progress Against Strategic R&D Priorities
